Target intelligence / Profile preview

Ribosomal protein L23a pseudogene 4 (RPL23AP4)

Target: RPL23AP4
Molecular classification: Other (Pseudogene; not a functional protein family member)

Overview

Ribosomal protein L23a pseudogene 4 (RPL23AP4) is a processed pseudogene found in the human genome. It is among a large number of pseudogenes related to the ribosomal protein L23a gene (RPL23A), which encodes a structural component of the 60S ribosomal subunit in active protein synthesis machinery. However, RPL23AP4 itself does not encode a functional protein and has no described biological activity or role in pathology or therapy. The function and significance of this pseudogene remain uncharacterized in scientific literature, and there is no evidence that it serves as a drug target, biomarker, or has clinical relevance[5].

Other names: RPL23A_42_1735RPL23AP4

Beyond the preview

Go deeper on Ribosomal protein L23a pseudogene 4 (RPL23AP4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L23a pseudogene 4 (RPL23AP4).

Explore the full profile